Skip to content
← Full study record

NCT00931528 · FLOW

Participant flow

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy · Source last updated 2018-02-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
    id
    FG000
    title
    Tadalafil
  2. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
    id
    FG001
    title
    Placebo
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        12
      type
      Protocol Violation
    2. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        12
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        13
      type
      Lost to Follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        23
      type
      Assessment outside of Time Frame
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        121
      2. group Id
        FG001
        num Subjects
        121
      type
      STARTED
    2. achievements
      1. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG000
        num Subjects
        80
      2. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG001
        num Subjects
        61
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        41
      2. group Id
        FG001
        num Subjects
        60
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
    id
    FG000
    title
    Tadalafil
  2. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
    id
    FG001
    title
    Placebo
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        12
      type
      Protocol Violation
    2. reasons
      1. group Id
        FG000
        num Subjects
        4
      2. group Id
        FG001
        num Subjects
        12
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        13
      type
      Lost to Follow-up
    4. reasons
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        23
      type
      Assessment outside of Time Frame
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        121
      2. group Id
        FG001
        num Subjects
        121
      type
      STARTED
    2. achievements
      1. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG000
        num Subjects
        80
      2. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG001
        num Subjects
        61
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        41
      2. group Id
        FG001
        num Subjects
        60
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice